Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

MINDRAY In-Vitro Diagnostics

As a global leader in in-vitro diagnostics, Mindray provides a wide range of efficient, reliable IVD solutions for la... read more Featured Products: More products

Download Mobile App





Mindray Demonstrates Hematology and Total Laboratory Automation Solutions

By LabMedica International staff writers
Posted on 29 Jul 2025

Mindray (Shenzhen, China) is returning to ADLM after five years to unveil cutting-edge lab innovations and clinical insights. More...

At ADLM 2025, Mindray is highlighting the MT 8000 Intelligent TLA Solution designed for streamlined, automated laboratory operations. The MT 8000 Intelligent TLA Solution promises to revolutionize lab operations with unmatched flexibility and automation across five critical disciplines. Mindray is also highlighting the M6000 Laboratory Automation System that can empower ultra-high volume laboratories with high processing speed, less hands-on time, great cost efficiency, and standardized analytical quality.

Visitors to Mindray’s booth at ADLM 2025 can also experience its ALL IN ONE Hematology Solution that brings greater efficiency to hematology testing with simplified workflows and ease of operation. It enables end-to-end automation throughout the process, from tube sorting through to analysis of CBC, ESR, CRP, and HbA1c with a single EDTA tube, smear preparation, and slide reading. The solution is ideal for core or centralized laboratories with mid-to-high sample volumes and a high demand for turnaround times.

The focus is also on the CAL 9000 New Generation Cellular Analysis Line that showcases Mindray's expertise and innovation for large-volume hematology laboratories. Mindray is also showcasing the M1000 chemistry and immunoassay integrated solution for large-scale laboratories alongside the M980 chemistry and immunoassay integrated solution for mid-scale laboratories.

Mindray is presenting the FA-N60 next-generation scalable blood culture system that features real-time blood volume monitoring, an intelligent satellite information transmission system, and newly designed culture bottles. It enables rapid diagnosis of bloodstream infections with an optimized workflow. In addition, visitors to the company’s booth can experience the CX-6000 Series next-generation mid-end automated coagulation analyzer that has been developed based on the CX-9000 Series platform.

Also being highlighted at ADLM 2025 is the Mindray EU 8600 (and EU 8600 GT) fully automated urinalysis system designed for high-throughput laboratories, featuring multi-depth-of-field fusion, vibration-proof system, 2K full-color clear imaging, and high analysis volume for sediment particles. In addition to presenting innovative breakthroughs,

Additionally, Mindray is also holding expert-led workshops shaping the future of laboratory diagnostics. This includes a workshop on hs-cTnI (high-sensitivity cardiac troponin I) and expert-led discussions on advancing myocardial injury management. Mindray’s focus on high-sensitivity cardiac troponin I clinical insights highlights important advances and ongoing challenges in myocardial injury management—an essential conversation for improving patient outcomes.

Related Links:
Mindray


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Aspiration System
VACUSAFE
New
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
Automated Clinical Chemistry Analyzer
Envoy 500+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The researchers Manel Pérez Pons y Carlos Rodriguez Muñoz at the IRBLleida laboratory (Photo courtesy of IRBLleida)

New Blood RNA Markers Help Advance Precision Medicine for Respiratory Patients

Risk stratification in hospitalized respiratory disease, particularly among older adults with COVID-19, remains challenging despite rich clinical datasets. Blood-based non-coding RNA biomarkers are promising,... Read more

Microbiology

view channel
Image: The “broth” used to monitor red blood cell depletion in whole blood spiked with one colony-forming-unit of E. coli bacteria, each incubated at different orbital shaking speeds—left to right: 0 RPM, 65 RPM, 120 RPM and 200 RPM—after four hours of incubation. This culturing raises a bacteria-rich, plasma-like layer of bacteria to the top of the vials, while clusters of stuck blood cells known as a Rouleaux formation sink to the bottom. (Image Credit: Pak Kin Wong)

New Diagnostic Workflow Identifies Bloodstream Pathogens and Antibiotic Response in Hours

Sepsis is a life-threatening complication of infection that affects more than 1.5 million patients annually in the United States and contributes to roughly one in three in-hospital deaths.... Read more

Pathology

view channel
Image: Researchers evaluated AI models that quantify tumor-infiltrating lymphocytes (TIL) on routine breast tissue slides, where higher TIL levels reflect stronger antitumor response and improved breast cancer outcomes (Image Credit: Shutterstock)

AI Matches Pathologists in Predicting Breast Cancer Prognosis from Immune Cells

Breast cancer is the most common cancer in Australian women, with more than 20,000 cases each year. Prognosis can be informed by counting tumor-infiltrating lymphocytes (TILs) on routine pathology slides,... Read more

Industry

view channel
Image: RaDaR ST uses a tumor-informed approach that identifies up to 48 patient-specific variants through whole-exome sequencing and tracks those variants in plasma to detect circulating tumor DNA (ctDNA) at very low variant allele fractions (VAFs) (Photo courtesy of Neogenomics)

Tumor-Informed MRD Assay Gains Medicare Coverage for Immunotherapy Monitoring

NeoGenomics’ RaDaR ST molecular residual disease (MRD) assay has received expanded coverage from the Centers for Medicare & Medicaid Services’ Molecular Diagnostic Services Program (MolDX) for monitoring... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.